Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Korro Bio (KRRO) Debt to Equity (2019 - 2023)

Korro Bio's Debt to Equity history spans 5 years, with the latest figure at -$0.1 for Q1 2023.

  • For the quarter ending Q1 2023, Debt to Equity fell 174.12% year-over-year to -$0.1, compared with a TTM value of -$0.1 through Mar 2023, down 174.12%, and an annual FY2022 reading of -$0.14, up 59.75% over the prior year.
  • Debt to Equity for Q1 2023 was -$0.1 at Korro Bio, up from -$0.14 in the prior quarter.
  • The five-year high for Debt to Equity was $0.18 in Q3 2022, with the low at -$0.36 in Q4 2021.
  • Average Debt to Equity over 5 years is $0.02, with a median of $0.08 recorded in 2021.
  • Year-over-year, Debt to Equity soared 7145.27% in 2020 and then crashed 556.05% in 2021.
  • Tracing KRRO's Debt to Equity over 5 years: stood at $0.0 in 2019, then soared by 7145.27% to $0.08 in 2020, then crashed by 556.05% to -$0.36 in 2021, then soared by 59.75% to -$0.14 in 2022, then soared by 31.02% to -$0.1 in 2023.
  • Per Business Quant, the three most recent readings for KRRO's Debt to Equity are -$0.1 (Q1 2023), -$0.14 (Q4 2022), and $0.18 (Q3 2022).